Company Filing History:
Years Active: 2024-2025
Title: Jiong Lan: Innovator in Pharmaceutical Development
Introduction
Jiong Lan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific gene mutations. With a total of 2 patents, his work is paving the way for advancements in cancer treatment.
Latest Patents
Jiong Lan's latest patents include a polymorph of a CDK9 inhibitor and a preparation method for the polymorph and its applications. This invention provides a novel polymorph of a CDK9 inhibitor, specifically detailing a compound that has potential applications in pharmaceutical compositions. Additionally, he has developed a substituted heterocyclic fused cyclic compound that exhibits a selective inhibitory effect on KRAS gene mutations, which is crucial for the preparation of cancer drugs.
Career Highlights
Throughout his career, Jiong Lan has worked with notable companies such as Zhejiang Genfleet Therapeutics Co., Ltd. and Genfleet Therapeutics (Shanghai) Inc. His expertise in pharmaceutical development has positioned him as a key player in the industry.
Collaborations
Jiong Lan has collaborated with esteemed colleagues, including Fusheng Zhou and Tao Jiang. Their combined efforts have contributed to the advancement of innovative therapeutic solutions.
Conclusion
Jiong Lan's contributions to pharmaceutical innovation are noteworthy, particularly in the realm of cancer treatment. His patents reflect a commitment to developing effective therapies that address critical health challenges.